143 related articles for article (PubMed ID: 24098454)
1. The presence of CXCR4-using HIV-1 prior to start of antiretroviral therapy is an independent predictor of delayed viral suppression.
Gijsbers EF; van Sighem A; Harskamp AM; Welkers MR; de Wolf F; Brinkman K; Prins JM; Schuitemaker H; van 't Wout AB; Kootstra NA
PLoS One; 2013; 8(10):e76255. PubMed ID: 24098454
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic Immune Recovery and Reduction of CXCR4-Tropic HIV-1.
Bader J; Däumer M; Schöni-Affolter F; Böni J; Gorgievski-Hrisoho M; Martinetti G; Thielen A; Klimkait T;
Clin Infect Dis; 2017 Feb; 64(3):295-300. PubMed ID: 27838645
[TBL] [Abstract][Full Text] [Related]
3. HIV-1 coreceptor usage and CXCR4-specific viral load predict clinical disease progression during combination antiretroviral therapy.
Weiser B; Philpott S; Klimkait T; Burger H; Kitchen C; Bürgisser P; Gorgievski M; Perrin L; Piffaretti JC; Ledergerber B;
AIDS; 2008 Feb; 22(4):469-79. PubMed ID: 18301059
[TBL] [Abstract][Full Text] [Related]
4. CD4 T cell decline following HIV seroconversion in individuals with and without CXCR4-tropic virus.
Ghosn J; Bayan T; Meixenberger K; Tran L; Frange P; d'Arminio Monforte A; Zangerle R; de Mendoza C; Krastinova E; Porter K; Meyer L; Chaix ML;
J Antimicrob Chemother; 2017 Oct; 72(10):2862-2868. PubMed ID: 29091208
[TBL] [Abstract][Full Text] [Related]
5. Depletion of naive CD4 T cells by CXCR4-using HIV-1 variants occurs mainly through increased T-cell death and activation.
Hazenberg MD; Otto SA; Hamann D; Roos MT; Schuitemaker H; de Boer RJ; Miedema F
AIDS; 2003 Jul; 17(10):1419-24. PubMed ID: 12824778
[TBL] [Abstract][Full Text] [Related]
6. Emergence of CXCR4-tropic HIV-1 variants followed by rapid disease progression in hemophiliac slow progressors.
Hayashida T; Tsuchiya K; Kikuchi Y; Oka S; Gatanaga H
PLoS One; 2017; 12(5):e0177033. PubMed ID: 28472121
[TBL] [Abstract][Full Text] [Related]
7. The impact of HIV tropism on decreases in CD4 cell count, clinical progression, and subsequent response to a first antiretroviral therapy regimen.
Waters L; Mandalia S; Randell P; Wildfire A; Gazzard B; Moyle G
Clin Infect Dis; 2008 May; 46(10):1617-23. PubMed ID: 18419499
[TBL] [Abstract][Full Text] [Related]
8. Naive T-cell depletion related to infection by X4 human immunodeficiency virus type 1 in poor immunological responders to highly active antiretroviral therapy.
Delobel P; Nugeyre MT; Cazabat M; Sandres-Sauné K; Pasquier C; Cuzin L; Marchou B; Massip P; Cheynier R; Barré-Sinoussi F; Izopet J; Israël N
J Virol; 2006 Oct; 80(20):10229-36. PubMed ID: 17005700
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of R5 and X4 HIV variants in antiretroviral treatment experienced patients with virologic failure.
Ferrer P; Tello M; Montecinos L; Tordecilla R; Rodríguez C; Beltrán C; Guzmán MA; Ferrés M; Pérez CM; Afani A
J Clin Virol; 2014 Jul; 60(3):290-4. PubMed ID: 24793966
[TBL] [Abstract][Full Text] [Related]
10. R5 to X4 switch of the predominant HIV-1 population in cellular reservoirs during effective highly active antiretroviral therapy.
Delobel P; Sandres-Sauné K; Cazabat M; Pasquier C; Marchou B; Massip P; Izopet J
J Acquir Immune Defic Syndr; 2005 Apr; 38(4):382-92. PubMed ID: 15764954
[TBL] [Abstract][Full Text] [Related]
11. Early viral load and CD4+ T cell count, but not percentage of CCR5+ or CXCR4+ CD4+ T cells, are associated with R5-to-X4 HIV type 1 virus evolution.
van Rij RP; Hazenberg MD; van Benthem BH; Otto SA; Prins M; Miedema F; Schuitemaker H
AIDS Res Hum Retroviruses; 2003 May; 19(5):389-98. PubMed ID: 12803997
[TBL] [Abstract][Full Text] [Related]
12. Pace of Coreceptor Tropism Switch in HIV-1-Infected Individuals after Recent Infection.
Arif MS; Hunter J; Léda AR; Zukurov JPL; Samer S; Camargo M; Galinskas J; Kallás EG; Komninakis SV; Janini LM; Sucupira MC; Diaz RS
J Virol; 2017 Oct; 91(19):. PubMed ID: 28659473
[TBL] [Abstract][Full Text] [Related]
13. CXCR4 overexpression during the course of HIV-1 infection correlates with the emergence of X4 strains.
Lin YL; Portales P; Segondy M; Baillat V; de Boever CM; Le Moing V; Réant B; Montes B; Clot J; Reynes J; Corbeau P
J Acquir Immune Defic Syndr; 2005 Aug; 39(5):530-6. PubMed ID: 16044003
[TBL] [Abstract][Full Text] [Related]
14. Molecular and clinical epidemiology of CXCR4-using HIV-1 in a large population of antiretroviral-naive individuals.
Brumme ZL; Goodrich J; Mayer HB; Brumme CJ; Henrick BM; Wynhoven B; Asselin JJ; Cheung PK; Hogg RS; Montaner JS; Harrigan PR
J Infect Dis; 2005 Aug; 192(3):466-74. PubMed ID: 15995960
[TBL] [Abstract][Full Text] [Related]
15. Rapid CD4 decline prior to antiretroviral therapy predicts subsequent failure to reconstitute despite HIV viral suppression.
Darraj M; Shafer LA; Chan S; Kasper K; Keynan Y
J Infect Public Health; 2018; 11(2):265-269. PubMed ID: 28826735
[TBL] [Abstract][Full Text] [Related]
16. Existence of Replication-Competent Minor Variants with Different Coreceptor Usage in Plasma from HIV-1-Infected Individuals.
Maeda Y; Takemura T; Chikata T; Kuwata T; Terasawa H; Fujimoto R; Kuse N; Akahoshi T; Murakoshi H; Tran GV; Zhang Y; Pham CH; Pham AHQ; Monde K; Sawa T; Matsushita S; Nguyen TV; Nguyen KV; Hasebe F; Yamashiro T; Takiguchi M
J Virol; 2020 Jun; 94(12):. PubMed ID: 32295903
[TBL] [Abstract][Full Text] [Related]
17. High CD4(+) T-cell surface CXCR4 density as a risk factor for R5 to X4 switch in the course of HIV-1 infection.
Fiser AL; Vincent T; Brieu N; Lin YL; Portalès P; Mettling C; Reynes J; Corbeau P
J Acquir Immune Defic Syndr; 2010 Dec; 55(5):529-35. PubMed ID: 20861743
[TBL] [Abstract][Full Text] [Related]
18. Co-receptor switch during HAART is independent of virological success.
Saracino A; Monno L; Cibelli DC; Punzi G; Brindicci G; Ladisa N; Tartaglia A; Lagioia A; Angarano G
J Med Virol; 2009 Dec; 81(12):2036-44. PubMed ID: 19856465
[TBL] [Abstract][Full Text] [Related]
19. CD4+ cell count 6 years after commencement of highly active antiretroviral therapy in persons with sustained virologic suppression.
Moore RD; Keruly JC
Clin Infect Dis; 2007 Feb; 44(3):441-6. PubMed ID: 17205456
[TBL] [Abstract][Full Text] [Related]
20. Next generation sequencing reveals a high frequency of CXCR4 utilizing viruses in HIV-1 chronically infected drug experienced individuals in South Africa.
Matume ND; Tebit DM; Gray LR; Hammarskjold ML; Rekosh D; Bessong PO
J Clin Virol; 2018 Jun; 103():81-87. PubMed ID: 29661652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
